Cardlytics Sees Q2 Sales $35.000M-$40.000M vs $37.519M Est

Benzinga Newsdesk www.benzinga.com Positive 84.5%

Neg 0% Neu 0% Pos 84.5%

Cardlytics (NASDAQ:CDLX) sees Q2 sales of $35.000 million-$40.000 million vs $37.519 million analyst estimate.

Comments

No comments yet. Be the first!